Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana L Blithe

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Biology of Reproduction|September 5, 2023
Novel progestogenic androgens for male contraception: design, synthesis, and activity of C7 α-substituted testosterone†Min S Lee, Deborah I Bunin, Anna M Furimsky, et al.
Biology of Reproduction|September 13, 2021
Contraceptive and Infertility Target DataBase: a contraceptive drug development tool for targeting and analysis of human reproductive specific tissues†Subarna Sinha, Merrill Knapp, John Pywtorak, et al.
Andrology|May 3, 2014
Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dimethandrolone undecanoate in man: a prototype oral male hormonal contraceptivePrasanth Surampudi, Stephanie T Page, Ronald S Swerdloff, et al.
The Journal of Clinical Endocrinology and Metabolism|September 26, 2018
Effects of 28 Days of Oral Dimethandrolone Undecanoate in Healthy Men: A Prototype Male PillArthi Thirumalai, Jonas Ceponis, John K Amory, et al.
Lancet (London, England)|February 2, 2010
Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysisAnna F Glasier, Sharon T Cameron, Paul M Fine, et al.
Contraception|April 17, 2020
Acceptability of oral dimethandrolone undecanoate in a 28-day placebo-controlled trial of a hormonal male contraceptive prototypeBrian T Nguyen, Maritza T Farrant, Bradley D Anawalt, et al.
Contraception|June 21, 2021
Acceptability of the oral hormonal male contraceptive prototype, 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trialBrian T Nguyen, Fiona Yuen, Maritza Farrant, et al.
Contraception|May 20, 2023
Design of an international male contraceptive efficacy trial using a self-administered daily transdermal gel containing testosterone and segesterone acetate (Nestorone)John K Amory, Diana L Blithe, Regine Sitruk-Ware, et al.
The Journal of Clinical Endocrinology and Metabolism|January 25, 2020
Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy MenFiona Yuen, Arthi Thirumalai, Cindy Pham, et al.
Contraception|May 17, 2020
Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetateMelissa J Chen, Mitchell D Creinin, David K Turok, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Biology of Reproduction|September 5, 2023
Novel progestogenic androgens for male contraception: design, synthesis, and activity of C7 α-substituted testosterone†Min S Lee, Deborah I Bunin, Anna M Furimsky, et al.
Biology of Reproduction|September 13, 2021
Contraceptive and Infertility Target DataBase: a contraceptive drug development tool for targeting and analysis of human reproductive specific tissues†Subarna Sinha, Merrill Knapp, John Pywtorak, et al.
Andrology|May 3, 2014
Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dimethandrolone undecanoate in man: a prototype oral male hormonal contraceptivePrasanth Surampudi, Stephanie T Page, Ronald S Swerdloff, et al.
The Journal of Clinical Endocrinology and Metabolism|September 26, 2018
Effects of 28 Days of Oral Dimethandrolone Undecanoate in Healthy Men: A Prototype Male PillArthi Thirumalai, Jonas Ceponis, John K Amory, et al.
Lancet (London, England)|February 2, 2010
Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysisAnna F Glasier, Sharon T Cameron, Paul M Fine, et al.
Contraception|April 17, 2020
Acceptability of oral dimethandrolone undecanoate in a 28-day placebo-controlled trial of a hormonal male contraceptive prototypeBrian T Nguyen, Maritza T Farrant, Bradley D Anawalt, et al.
Contraception|June 21, 2021
Acceptability of the oral hormonal male contraceptive prototype, 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trialBrian T Nguyen, Fiona Yuen, Maritza Farrant, et al.
Contraception|May 20, 2023
Design of an international male contraceptive efficacy trial using a self-administered daily transdermal gel containing testosterone and segesterone acetate (Nestorone)John K Amory, Diana L Blithe, Regine Sitruk-Ware, et al.
The Journal of Clinical Endocrinology and Metabolism|January 25, 2020
Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy MenFiona Yuen, Arthi Thirumalai, Cindy Pham, et al.
Contraception|May 17, 2020
Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetateMelissa J Chen, Mitchell D Creinin, David K Turok, et al.
Pageof 6